<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03232749</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201700603</org_study_id>
    <nct_id>NCT03232749</nct_id>
  </id_info>
  <brief_title>Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint</brief_title>
  <official_title>Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the effectiveness of a single cortisone injection in patients with
      shoulder osteoarthritis over a 6-month period, and identify clinical and radiographic factors
      to help predict how a patient with shoulder osteoarthritis will respond to a cortisone
      injection utilizing ultrasound guidance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to assess the effectiveness of intraarticular corticosteroid
      injections (IACSI) for glenohumeral arthritis by 1) through patient-reported outcomes and 2)
      identifying clinical and radiographic predictors of IACSI success.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 18, 2018</start_date>
  <completion_date type="Anticipated">July 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess the effectiveness of IACSI in patients with primary osteoarthritis in the shoulder by evaluating the change in ASES scores.</measure>
    <time_frame>Baseline and post-injection: 5-10 minutes, 2 weeks, 1 month, 2 months, 3 months, 6 months</time_frame>
    <description>ASES (American Shoulder &amp; Elbow Surgeon) score improvement &gt; 20.9 points</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assess the effectiveness of IACSI in patients with primary osteoarthritis in the shoulder</measure>
    <time_frame>Baseline and post-injection: 5-10 minutes, 2 weeks, 1 month, 2 months, 3 months, 6 months</time_frame>
    <description>VAS (Visual Analog Scale) pain score improvement &gt; 1.4 points</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assess the effectiveness of IACSI in patients with primary osteoarthritis in the shoulder</measure>
    <time_frame>Baseline and post-injection: 5-10 minutes, 2 weeks, 1 month, 2 months, 3 months, 6 months</time_frame>
    <description>SST (Simple Shoulder Test) score improvement &gt; 2.4 points</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Samilson &amp; Prieto Radiological Classification</measure>
    <time_frame>Baseline</time_frame>
    <description>Mild Arthrosis: inferior humeral and/or glenoid exostosis &lt; 3mm in height. Moderate Arthrosis: inferior humeral and/or glenoid exostosis measuring 3mm to 7mm slight gleno-humeral irregularity. Severe Arthrosis: inferior humeral and/or glenoid exostosis measuring &gt; 7mm gleno-humeral joint narrowing and sclerosis.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Osteoarthritis of the Glenohumeral Joint</condition>
  <arm_group>
    <arm_group_label>symptomatic primary osteoarthritis of the shoulder</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects enrolled into the study will be those who have failed previous treatment including over-the-counter analgesics and activity modification, and have elected to receive a medically-indicated, ultrasound-guided IACSI in the shoulder</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intraarticular corticosteroid injections (IACSI)</intervention_name>
    <description>ultrasound-guided IACSI will be administered</description>
    <arm_group_label>symptomatic primary osteoarthritis of the shoulder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>corticosteroid injections</intervention_name>
    <description>Corticosteroid will be administered is used to treat pain and swelling that occurs with arthritis and other joint disorder</description>
    <arm_group_label>symptomatic primary osteoarthritis of the shoulder</arm_group_label>
    <other_name>Methylprednisolone, Depo-medrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>ultrasound-guided IACSI</description>
    <arm_group_label>symptomatic primary osteoarthritis of the shoulder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a diagnosis of symptomatic primary osteoarthritis of the shoulder will
             be recruited from the patient population seeking treatment at the Orthopaedics Sports
             Medicine Institute.

          -  those who have failed previous treatment including over-the-counter analgesics and
             activity modification

          -  have elected to receive a medically-indicated, ultrasound-guided IACSI in the
             shoulder.

        Exclusion Criteria:

          -  Patients will be excluded from the study for any of the following reasons:

          -  Post traumatic osteoarthritis

          -  Inflammatory osteoarthritis

          -  Imaging confirmed rotator cuff tear

          -  Prior ipsilateral shoulder surgery

          -  Memory loss or inability to complete study measures

          -  History of allergy to injection medications

          -  Diabetic patients with patient-reported fasting blood glucose &gt;200

          -  Prior injection in the ipsilateral shoulder within three months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bradley Schoch, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michelle Bruner, MSc</last_name>
    <phone>352-273-7337</phone>
    <email>bruneml@ortho.ufl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aimee Struk, MEd, MBA</last_name>
    <phone>352-273-7419</phone>
    <email>strukam@ortho.ufl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UF and Shands Orthopaedics and Sports Medicine Institute</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris J Koenig, M.S., ATC</last_name>
      <phone>352-273-7372</phone>
      <email>koenicj@ortho.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Bradley Schoch, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UF Health Orthopaedics and Sports Medicine Institute</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aimee M Struk, MEd</last_name>
      <phone>352-273-7419</phone>
      <email>strukam@ortho.ufl.edu</email>
    </contact>
    <contact_backup>
      <last_name>MaryBeth Horodyski, Ed.D.</last_name>
      <phone>352-273-7074</phone>
      <email>horomb@ortho.ufl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Bradley Schoch, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2017</study_first_submitted>
  <study_first_submitted_qc>July 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2017</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylprednisolone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

